Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript
Summarize this article with:
SA Transcripts159.3K FollowersFollow5ShareSaveCommentsQ1: 2026-04-14 Earnings SummaryInsightsTranscript InsightsPlay CallPlay CallEPS of $2.70 beats by $0.02 | Revenue of $24.06B (9.91% Y/Y) beats by $450.34M Johnson & Johnson (JNJ) Q1 2026 Earnings Call April 14, 2026 8:30 AM EDT Company Participants Darren Snellgrove - Vice President of Investor RelationsJoaquin Duato - CEO & ChairmanJoseph Wolk - Executive VP & CFOJennifer Taubert - Executive VP & Worldwide Chairman of Innovative MedicineJohn Reed - Executive Vice President of Innovative Medicine and R&DTim Schmid - Executive VP & Worldwide Chairman of MedTech Conference Call Participants Terence Flynn - Morgan Stanley, Research DivisionLarry Biegelsen - Wells Fargo Securities, LLC, Research DivisionAsad Haider - Goldman Sachs Group, Inc., Research DivisionChristopher Schott - JPMorgan Chase & Co, Research DivisionShagun Singh Chadha - RBC Capital Markets, Research DivisionAlexandria Hammond - Wolfe Research, LLCJoanne Wuensch - Citigroup Inc., Research DivisionDavid Risinger - Leerink Partners LLC, Research DivisionMatthew Miksic - Barclays Bank PLC, Research Division Presentation Operator Good morning, and welcome to Johnson & Johnson's First Quarter 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded. [Operator Instructions] I will now turn the call over to Johnson & Johnson. You may begin. Darren SnellgroveVice President of Investor Relations Hello, everyone. This is Darren Snellgrove, Vice President of Investor Relations for Johnson & Johnson. Welcome to our company's review of business results for the first quarter of 2026 and our financial outlook for the full year. First, a few logistics. As a reminder, today's presentation and associated schedules are available on the Investor Relations section of the Johnson & Johnson website at investor.jnj.com. Please note that this presentation contains forward-looking statements regarding, among other things, the company's future operating and financial performance, market position and business strategy. You are cautioned not to rely on these forward-looking statements, which are based on the current expectations of future events using the information available as of the date of this recording and are subject